HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Amir Onn Selected Research
Amir Onn Research Topics
Disease
41
Neoplasms (Cancer)
01/2022 - 06/2002
27
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2022 - 06/2002
24
Lung Neoplasms (Lung Cancer)
08/2021 - 06/2002
7
Neoplasm Metastasis (Metastasis)
01/2021 - 06/2002
6
Adenocarcinoma of Lung
10/2019 - 06/2002
5
Adenocarcinoma
01/2022 - 01/2017
5
Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2017 - 06/2002
3
Carcinoma (Carcinomatosis)
01/2021 - 10/2004
3
Small Cell Lung Carcinoma (Small Cell Lung Cancer)
12/2019 - 11/2003
3
Melanoma (Melanoma, Malignant)
09/2013 - 02/2004
2
Malignant Pleural Effusion
01/2022 - 09/2014
2
Pleural Effusion (Pleural Effusions)
01/2022 - 09/2014
2
Asthma (Bronchial Asthma)
05/2021 - 11/2002
1
Immune System Diseases (Immune Disorders)
01/2022
1
Testicular Neoplasms (Testicular Cancer)
01/2022
1
Respiratory Hypersensitivity
05/2021
1
Pain (Aches)
01/2020
1
Disease Progression
12/2019
1
Weight Loss (Weight Reduction)
01/2019
1
Microsatellite Instability
01/2018
1
Lewis Lung Carcinoma
10/2014
Drug/Important Bio-Agent (IBA)
8
ErbB Receptors (EGF Receptor)
IBA
04/2022 - 01/2004
7
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
01/2022 - 11/2003
6
Tyrosine Kinase Inhibitors
IBA
04/2022 - 12/2004
6
Biomarkers (Surrogate Marker)
IBA
01/2022 - 09/2013
6
Proteins (Proteins, Gene)
FDA Link
01/2022 - 01/2004
5
Paclitaxel (Taxol)
FDA Link
Generic
10/2014 - 11/2003
4
Ligands
IBA
01/2022 - 10/2007
4
Pharmaceutical Preparations
IBA
01/2021 - 02/2004
4
Biological Products
IBA
06/2013 - 11/2002
3
Phosphotransferases (Kinase)
IBA
01/2021 - 02/2007
3
MicroRNAs (MicroRNA)
IBA
10/2020 - 09/2013
3
vandetanib (ZD6474)
IBA
09/2014 - 02/2007
3
Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)
IBA
11/2013 - 02/2004
3
Gefitinib (Iressa)
FDA Link
07/2012 - 06/2005
3
Protein-Tyrosine Kinases (Tyrosine Kinase)
IBA
10/2007 - 01/2005
3
Interleukin-8 (Interleukin 8)
IBA
03/2007 - 11/2003
2
B7-H1 Antigen
IBA
01/2022 - 01/2018
2
Axitinib (AG 013736)
IBA
01/2022 - 04/2021
2
Peptides (Polypeptides)
IBA
01/2022 - 02/2016
2
Nivolumab
IBA
01/2021 - 01/2019
2
Tyrosine (L-Tyrosine)
FDA Link
01/2021 - 02/2007
2
Platinum
IBA
12/2019 - 01/2017
2
Etoposide (VP 16)
FDA Link
Generic
12/2019 - 02/2013
2
Antibodies
IBA
11/2018 - 10/2009
2
Pemetrexed (MTA)
FDA Link
01/2017 - 10/2014
2
Cisplatin (Platino)
FDA Link
Generic
10/2014 - 02/2013
2
Vascular Endothelial Growth Factor Receptors (VEGF Receptors)
IBA
09/2014 - 02/2007
2
Transforming Growth Factor alpha (TGF-alpha)
IBA
10/2007 - 01/2004
2
Epidermal Growth Factor (EGF)
IBA
10/2007 - 02/2007
2
Angiogenesis Inhibitors
IBA
03/2007 - 05/2005
2
Matrix Metalloproteinase 2 (Gelatinase A)
IBA
03/2007 - 06/2004
2
Intercellular Signaling Peptides and Proteins (Growth Factors)
IBA
06/2005 - 01/2003
2
Imatinib Mesylate (Gleevec)
FDA Link
01/2005 - 02/2004
2
Platelet-Derived Growth Factor
IBA
01/2005 - 02/2004
1
Neoplasm Antigens (Tumor Antigens)
IBA
01/2022
1
palbociclib
IBA
01/2022
1
pembrolizumab
IBA
01/2022
1
alectinib
IBA
01/2022
1
avelumab
IBA
01/2022
1
Antigens
IBA
01/2022
1
durvalumab
IBA
01/2022
1
Paraffin
IBA
08/2021
1
Messenger RNA (mRNA)
IBA
08/2021
1
Granzymes (Granzyme)
IBA
08/2021
1
Formaldehyde (Formol)
FDA Link
08/2021
1
Bovine Serum Albumin
IBA
08/2021
1
Methacholine Chloride (Methacholine)
FDA Link
05/2021
1
Everolimus
FDA Link
04/2021
1
Calcium
IBA
01/2021
1
Interferons
IBA
01/2021
1
Nerve Growth Factors (Neurotrophins)
IBA
01/2021
1
Immune Checkpoint Inhibitors
IBA
01/2021
1
Cytokines
IBA
01/2021
1
Complement System Proteins (Complement)
IBA
12/2020
1
Cell-Free Nucleic Acids
IBA
12/2020
1
Mechanistic Target of Rapamycin Complex 1
IBA
01/2020
1
Conditioned Culture Media
IBA
01/2020
1
cyclopropapyrroloindole
IBA
10/2019
1
RNA (Ribonucleic Acid)
IBA
01/2019
1
DNA (Deoxyribonucleic Acid)
IBA
01/2019
1
Mitogen-Activated Protein Kinase Kinases (MEKs)
IBA
01/2019
1
Albumins
IBA
01/2019
1
osimertinib
IBA
11/2018
1
Cetuximab (Erbitux)
FDA Link
11/2018
1
Thyroid Nuclear Factor 1
IBA
01/2017
1
big gastrin
IBA
02/2016
1
pro-gastrin-releasing peptide (31-98)
IBA
02/2016
1
Growth Factor Receptors
IBA
10/2014
Therapy/Procedure
19
Therapeutics
01/2022 - 06/2002
9
Drug Therapy (Chemotherapy)
01/2021 - 06/2005
7
Immunotherapy
01/2022 - 01/2019
7
Radiotherapy
06/2021 - 06/2005
3
Molecular Targeted Therapy
10/2005 - 05/2005
2
Precision Medicine
01/2021 - 01/2019
2
Catheters
09/2014 - 11/2007
1
Ambulatory Care (Outpatient Care)
01/2020
1
Tattooing
01/2018
1
Electronic Nose
10/2017
1
Combination Drug Therapy (Combination Chemotherapy)
01/2017